2023
DOI: 10.1186/s12885-023-11251-0
|View full text |Cite
|
Sign up to set email alerts
|

Preoperative sarcopenia combined with prognostic nutritional index predicts long-term prognosis of radical gastrectomy with advanced gastric cancer: a comprehensive analysis of two-center study

Abstract: Purpose This study aims to investigate the predictive value of the combined index smni(skeletal muscle index (SMI)-prognostic nutrition index(PNI)) for the postoperative survival of patients with advanced gastric cancer(AGC). Methods 650 patients with AGC from two centers (290 cases from the First Affiliated Hospital of Dalian University and 360 points from the Fujian Medical University Union Hospital) were selected as the study subjects based on u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 67 publications
0
2
0
Order By: Relevance
“…Sarcopenia and HRQoL are established risk factors for poor survival and tumor growth in upper GI tumors [ 10 , 12 , 19 , 41 , 62 , 63 , 64 , 65 , 66 , 67 ]. Sarcopenia has traditionally been measured through the CT-graphically obtained SMI, while HRQoL is obtained through patient questionnaires.…”
Section: Discussionmentioning
confidence: 99%
“…Sarcopenia and HRQoL are established risk factors for poor survival and tumor growth in upper GI tumors [ 10 , 12 , 19 , 41 , 62 , 63 , 64 , 65 , 66 , 67 ]. Sarcopenia has traditionally been measured through the CT-graphically obtained SMI, while HRQoL is obtained through patient questionnaires.…”
Section: Discussionmentioning
confidence: 99%
“…When compared with GNRI, most patients that were divided by an Alb level cutoff were categorized as being in the Alb-high group (134 and 41 in high and low groups, respectively, for Alb; vs. 109 and 66 in high and low groups, respectively, for GNRI). Considering the substantial contribution of the Alb level to predicting OS in this study, and recent evidence on the efficacy of complex biomarkers, including serum Alb [21,22], the GNRI was therefore selected for this study. With regard to prolonged TTCR, the following were revealed in univariate analysis to be independent prognostic factors when initial treatment was started: existence of symptoms (HR: 1.87, 95% CI: 1.16-3.03), upfront AA treatment (HR: 0.38, 95% CI: 0.24-0.60), low CRP level (HR: 0.45, 95% CI: 0.28-0.74), and high GNRI (HR: 0.44, 95% CI: 0.28-0.69).…”
Section: Identification Of Prognostic Factors For Ttcr and Osmentioning
confidence: 99%